SCN9A and paroxysmal extreme pain disorder: Lastly, variants in SCN9A are associated with paroxysmal extreme pain disorder (PEPD), a rare autosomal-dominant disorder of pain processing and autonomic function with neonatal to infantile onset, where individuals experience sudden attacks of excruciating pain with no response to conventional analgesic medication [5].